Clinical trial · Observational
Compliant Analysis of Patient Samples and Data
Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies and/or Population-based Analysis
NCT04364503CI-TRIAL-00118793enrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Infectious Disease | — | UNRESOLVED | — |
| Pregnancy Related | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multiple interventions depending on diagnostic test being run. | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Remnant samples and data for research and development
- timeFrame
- Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.
- description
- Remnant samples and data for research and development
- measure
- Sample and data collection from subjects of scientific interest
- timeFrame
- Prospective collection. Samples and data may be collected for up to 12 months after enrollment
- description
- Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Arm 1 * All samples and data are de-identified and HIPAA compliant * Arm 2 * Subject is of scientific interest to the Sponsor or treating physician * Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected. Exclusion Criteria: * Arm 1 * Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development * Arm 2 * Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.